menu
About Us
Classes Of Business
HMO Reinsurance
Provider Excess Of Less
Medical Reinsurance
Employer Stop Loss
Client Captive Programs
Cell & Gene Therapy
Cost Containment
News
Contact Us
News
US FDA grants accelerated approval for Iovance’s skin cancer therapy
on
February 20, 2024
(updated March 19, 2024)
| Category:
News
US FDA grants accelerated approval for Iovance’s skin cancer therapy
Click here to download PDF
